Variations in RAD21 protein expression in clinical samples were reflected by gene expression analysis using qRT-PCR of a panel of breast cancer cell lines (Figure 3A), and by microarray profiling of 36 breast cancer cell lines derived from Hollestelle et al. [19] (Figure 3B). This evidence concerns the gene RAD21 and breast cancer.